Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Central Nervous System Diseases | 5 | 2016 | 519 | 1.190 |
Why?
|
Spinal Cord | 6 | 2017 | 1786 | 0.870 |
Why?
|
Subacute Combined Degeneration | 1 | 2022 | 2 | 0.830 |
Why?
|
Sodium Channels | 8 | 2008 | 337 | 0.790 |
Why?
|
Nitrous Oxide | 1 | 2022 | 166 | 0.770 |
Why?
|
CADASIL | 1 | 2022 | 83 | 0.760 |
Why?
|
Neurology | 2 | 2021 | 784 | 0.710 |
Why?
|
Intracranial Thrombosis | 1 | 2021 | 109 | 0.690 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 109 | 0.680 |
Why?
|
Brain Infarction | 2 | 2014 | 285 | 0.660 |
Why?
|
Radiation Injuries | 2 | 2017 | 1181 | 0.650 |
Why?
|
Stroke | 8 | 2022 | 9739 | 0.640 |
Why?
|
Nervous System Diseases | 4 | 2022 | 1657 | 0.610 |
Why?
|
Spinal Cord Diseases | 2 | 2022 | 291 | 0.600 |
Why?
|
Cranial Nerves | 2 | 2020 | 97 | 0.560 |
Why?
|
Anesthetics, Inhalation | 1 | 2022 | 573 | 0.560 |
Why?
|
Giant Cell Arteritis | 1 | 2021 | 308 | 0.560 |
Why?
|
Paraneoplastic Cerebellar Degeneration | 1 | 2016 | 13 | 0.550 |
Why?
|
Brain Diseases | 2 | 2017 | 1552 | 0.530 |
Why?
|
Magnetic Resonance Imaging | 26 | 2022 | 36547 | 0.510 |
Why?
|
Cerebral Veins | 2 | 2014 | 157 | 0.500 |
Why?
|
Myelitis | 1 | 2016 | 49 | 0.500 |
Why?
|
Intracranial Hypertension | 1 | 2017 | 190 | 0.490 |
Why?
|
Hypesthesia | 1 | 2016 | 106 | 0.490 |
Why?
|
Brain Stem | 3 | 2017 | 854 | 0.460 |
Why?
|
Leukoencephalopathies | 1 | 2017 | 259 | 0.460 |
Why?
|
Agraphia | 1 | 2014 | 8 | 0.460 |
Why?
|
Copper | 1 | 2016 | 365 | 0.450 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2014 | 171 | 0.440 |
Why?
|
Tuberculoma, Intracranial | 1 | 2013 | 8 | 0.440 |
Why?
|
Supraoptic Nucleus | 2 | 2004 | 28 | 0.430 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2014 | 50 | 0.430 |
Why?
|
Brain Edema | 1 | 2017 | 601 | 0.430 |
Why?
|
Radiotherapy | 2 | 2017 | 1491 | 0.430 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2013 | 23 | 0.420 |
Why?
|
Encephalomyelitis | 1 | 2013 | 37 | 0.420 |
Why?
|
Adenoviridae Infections | 1 | 2013 | 97 | 0.410 |
Why?
|
Magnetic Resonance Angiography | 4 | 2021 | 1429 | 0.410 |
Why?
|
Seizures | 2 | 2017 | 2997 | 0.400 |
Why?
|
Perceptual Disorders | 1 | 2014 | 199 | 0.390 |
Why?
|
Cytosine | 1 | 2013 | 212 | 0.390 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 166 | 0.380 |
Why?
|
Hospitalists | 1 | 2015 | 297 | 0.370 |
Why?
|
Aphasia | 1 | 2013 | 192 | 0.370 |
Why?
|
Brain Abscess | 1 | 2012 | 122 | 0.360 |
Why?
|
Anesthesia | 1 | 2022 | 1593 | 0.350 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2013 | 316 | 0.350 |
Why?
|
Temporal Lobe | 2 | 2017 | 1715 | 0.340 |
Why?
|
Skull Base | 1 | 2013 | 293 | 0.340 |
Why?
|
Inpatients | 1 | 2021 | 2563 | 0.330 |
Why?
|
Epilepsy | 5 | 2017 | 3317 | 0.330 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 340 | 0.320 |
Why?
|
Central Nervous System Neoplasms | 1 | 2017 | 918 | 0.320 |
Why?
|
Hippocampus | 4 | 2017 | 3772 | 0.320 |
Why?
|
Secondary Prevention | 2 | 2020 | 1470 | 0.320 |
Why?
|
Career Choice | 1 | 2015 | 769 | 0.310 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2004 | 1119 | 0.310 |
Why?
|
Parietal Lobe | 1 | 2014 | 859 | 0.310 |
Why?
|
Pregnancy Complications | 2 | 2014 | 2970 | 0.310 |
Why?
|
Brain | 13 | 2021 | 27179 | 0.310 |
Why?
|
Oligopeptides | 1 | 2014 | 1193 | 0.310 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2013 | 518 | 0.300 |
Why?
|
Cerebrovascular Circulation | 3 | 2016 | 2674 | 0.300 |
Why?
|
Editorial Policies | 1 | 2013 | 458 | 0.300 |
Why?
|
Encephalitis | 2 | 2022 | 440 | 0.300 |
Why?
|
Epilepsy, Absence | 2 | 2007 | 50 | 0.290 |
Why?
|
Ischemia | 1 | 2017 | 1901 | 0.290 |
Why?
|
Spine | 1 | 2015 | 1132 | 0.290 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2009 | 87 | 0.290 |
Why?
|
Cerebellar Diseases | 1 | 2009 | 227 | 0.280 |
Why?
|
Nerve Tissue Proteins | 7 | 2008 | 4394 | 0.280 |
Why?
|
Brain Neoplasms | 4 | 2017 | 9065 | 0.280 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20690 | 0.270 |
Why?
|
Disease Progression | 5 | 2017 | 13614 | 0.260 |
Why?
|
Encephalomyelitis, Acute Disseminated | 2 | 2017 | 67 | 0.260 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2649 | 0.260 |
Why?
|
Humans | 63 | 2022 | 765926 | 0.250 |
Why?
|
Intracranial Hemorrhages | 2 | 2019 | 809 | 0.250 |
Why?
|
Vasopressins | 2 | 2004 | 359 | 0.250 |
Why?
|
Headache Disorders, Primary | 1 | 2006 | 39 | 0.250 |
Why?
|
Diagnostic Imaging | 2 | 2017 | 3530 | 0.250 |
Why?
|
Neurocysticercosis | 2 | 2017 | 91 | 0.250 |
Why?
|
Optic Nerve | 1 | 2009 | 568 | 0.240 |
Why?
|
Neurons | 5 | 2004 | 9527 | 0.240 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2782 | 0.240 |
Why?
|
Water-Electrolyte Balance | 2 | 2004 | 326 | 0.240 |
Why?
|
Blindness | 1 | 2009 | 587 | 0.230 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13631 | 0.230 |
Why?
|
Neurons, Afferent | 2 | 2004 | 496 | 0.230 |
Why?
|
Ganglia, Spinal | 3 | 2003 | 528 | 0.230 |
Why?
|
Fatal Outcome | 4 | 2013 | 1835 | 0.220 |
Why?
|
Avian Proteins | 1 | 2004 | 77 | 0.220 |
Why?
|
Diffusion Tensor Imaging | 2 | 2013 | 2415 | 0.210 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2017 | 2805 | 0.210 |
Why?
|
Migraine Disorders | 1 | 2016 | 1729 | 0.210 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2006 | 269 | 0.210 |
Why?
|
Intracranial Aneurysm | 1 | 2013 | 1271 | 0.210 |
Why?
|
Nervous System Malformations | 2 | 2017 | 243 | 0.210 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2022 | 7 | 0.200 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 40 | 0.190 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2022 | 119 | 0.190 |
Why?
|
Putamen | 1 | 2022 | 288 | 0.180 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2003 | 710 | 0.180 |
Why?
|
Vagus Nerve | 1 | 2003 | 458 | 0.170 |
Why?
|
Nerve Degeneration | 2 | 2004 | 748 | 0.170 |
Why?
|
Eye Diseases | 1 | 2006 | 660 | 0.170 |
Why?
|
Mesencephalon | 1 | 2022 | 338 | 0.170 |
Why?
|
Peripheral Nerves | 1 | 2003 | 491 | 0.170 |
Why?
|
Antigens, Surface | 1 | 2004 | 1616 | 0.160 |
Why?
|
Herpes Zoster | 1 | 2022 | 252 | 0.160 |
Why?
|
Vitamin B 12 | 1 | 2022 | 531 | 0.160 |
Why?
|
Action Potentials | 2 | 2004 | 1837 | 0.160 |
Why?
|
Cranial Nerve Diseases | 1 | 2020 | 111 | 0.160 |
Why?
|
Multiple Sclerosis | 2 | 2011 | 3212 | 0.160 |
Why?
|
Up-Regulation | 4 | 2004 | 4130 | 0.160 |
Why?
|
Blood Proteins | 1 | 2004 | 1186 | 0.150 |
Why?
|
Brain Stem Hemorrhage, Traumatic | 1 | 2017 | 13 | 0.150 |
Why?
|
Cerebral Infarction | 1 | 2022 | 968 | 0.140 |
Why?
|
Diffuse Axonal Injury | 1 | 2017 | 49 | 0.140 |
Why?
|
Cerebral Cortex | 3 | 2022 | 5765 | 0.140 |
Why?
|
Electric Stimulation Therapy | 1 | 2003 | 634 | 0.140 |
Why?
|
Sclerosis | 2 | 2017 | 211 | 0.130 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5189 | 0.130 |
Why?
|
Female | 29 | 2022 | 396141 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 1995 | 0.130 |
Why?
|
Middle Aged | 18 | 2022 | 223016 | 0.130 |
Why?
|
Tremor | 1 | 2016 | 197 | 0.120 |
Why?
|
Male | 30 | 2022 | 363815 | 0.120 |
Why?
|
Functional Laterality | 2 | 2014 | 2243 | 0.120 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6360 | 0.120 |
Why?
|
Nimodipine | 1 | 2014 | 56 | 0.120 |
Why?
|
Meningitis, Viral | 1 | 2014 | 49 | 0.110 |
Why?
|
Heparin | 1 | 2021 | 1632 | 0.110 |
Why?
|
Piracetam | 1 | 2014 | 88 | 0.110 |
Why?
|
Anticonvulsants | 3 | 2017 | 1919 | 0.110 |
Why?
|
Coma, Post-Head Injury | 1 | 2013 | 21 | 0.110 |
Why?
|
Antigens, CD | 1 | 2004 | 4023 | 0.110 |
Why?
|
Cerebellar Ataxia | 1 | 2014 | 150 | 0.100 |
Why?
|
Nootropic Agents | 1 | 2014 | 159 | 0.100 |
Why?
|
Polyneuropathies | 1 | 2014 | 139 | 0.100 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2013 | 36 | 0.100 |
Why?
|
Prognosis | 5 | 2021 | 29890 | 0.100 |
Why?
|
Vertigo | 1 | 2014 | 205 | 0.100 |
Why?
|
Abducens Nerve Diseases | 1 | 2012 | 44 | 0.100 |
Why?
|
Propionibacterium acnes | 1 | 2012 | 59 | 0.100 |
Why?
|
Encephalitis, Viral | 1 | 2012 | 59 | 0.100 |
Why?
|
Paresthesia | 1 | 2013 | 159 | 0.100 |
Why?
|
Astrocytoma | 1 | 2016 | 772 | 0.100 |
Why?
|
Down-Regulation | 3 | 2004 | 2925 | 0.100 |
Why?
|
Animals | 18 | 2016 | 168735 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2879 | 0.090 |
Why?
|
HIV-2 | 1 | 2012 | 156 | 0.090 |
Why?
|
Pons | 1 | 2012 | 239 | 0.090 |
Why?
|
Gadolinium | 1 | 2016 | 966 | 0.090 |
Why?
|
Adult | 16 | 2022 | 223088 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2014 | 913 | 0.090 |
Why?
|
Anticoagulants | 2 | 2021 | 4856 | 0.090 |
Why?
|
Space Perception | 1 | 2014 | 469 | 0.090 |
Why?
|
Herpes Simplex | 1 | 2014 | 469 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 1 | 2013 | 245 | 0.090 |
Why?
|
Disease Models, Animal | 6 | 2007 | 18292 | 0.090 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2010 | 62 | 0.090 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 1022 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2015 | 561 | 0.080 |
Why?
|
Vasculitis | 1 | 2014 | 528 | 0.080 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11090 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 7 | 2008 | 8107 | 0.080 |
Why?
|
Rats | 9 | 2008 | 23708 | 0.080 |
Why?
|
Atrophy | 2 | 2011 | 1629 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 2 | 2012 | 2586 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2028 | 0.080 |
Why?
|
Kindling, Neurologic | 1 | 2008 | 24 | 0.080 |
Why?
|
Ophthalmic Artery | 1 | 2009 | 57 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2021 | 3615 | 0.080 |
Why?
|
Thrombocytosis | 1 | 2009 | 88 | 0.080 |
Why?
|
Ethosuximide | 1 | 2007 | 9 | 0.070 |
Why?
|
Aged | 11 | 2022 | 171163 | 0.070 |
Why?
|
Apoptosis | 1 | 2004 | 9505 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2157 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2008 | 12768 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 1042 | 0.070 |
Why?
|
Meningioma | 1 | 2016 | 1221 | 0.070 |
Why?
|
Cerebral Arteries | 1 | 2010 | 490 | 0.070 |
Why?
|
Young Adult | 8 | 2022 | 59857 | 0.070 |
Why?
|
Computational Biology | 1 | 1999 | 3562 | 0.070 |
Why?
|
Meningeal Neoplasms | 1 | 2016 | 1252 | 0.070 |
Why?
|
Fundus Oculi | 1 | 2009 | 542 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2021 | 2219 | 0.070 |
Why?
|
Arousal | 1 | 2013 | 1174 | 0.070 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2016 | 1076 | 0.070 |
Why?
|
Bhutan | 2 | 2017 | 61 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12973 | 0.070 |
Why?
|
Pregnancy | 3 | 2014 | 30230 | 0.070 |
Why?
|
Posterior Horn Cells | 2 | 2004 | 82 | 0.070 |
Why?
|
Models, Neurological | 1 | 2014 | 1748 | 0.070 |
Why?
|
Neuralgia | 2 | 2003 | 619 | 0.070 |
Why?
|
Anti-HIV Agents | 2 | 2012 | 4558 | 0.060 |
Why?
|
Viral Load | 2 | 2012 | 3385 | 0.060 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5128 | 0.060 |
Why?
|
DNA | 1 | 1999 | 7193 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2010 | 932 | 0.060 |
Why?
|
HIV Infections | 1 | 2012 | 17531 | 0.060 |
Why?
|
Indomethacin | 1 | 2006 | 322 | 0.060 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2011 | 952 | 0.060 |
Why?
|
Optic Nerve Diseases | 1 | 2009 | 342 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2713 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5889 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2010 | 1262 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2017 | 3799 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2014 | 3053 | 0.060 |
Why?
|
Rats, Wistar | 2 | 2007 | 1887 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7423 | 0.060 |
Why?
|
Sciatic Neuropathy | 1 | 2004 | 75 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2530 | 0.050 |
Why?
|
Contrast Media | 1 | 2016 | 5330 | 0.050 |
Why?
|
Radiation Dosage | 1 | 2011 | 1945 | 0.050 |
Why?
|
Gliosis | 1 | 2004 | 246 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 610 | 0.050 |
Why?
|
Carotid Stenosis | 1 | 2010 | 857 | 0.050 |
Why?
|
Psoas Abscess | 1 | 2002 | 11 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2653 | 0.050 |
Why?
|
Nerve Growth Factor | 1 | 2003 | 155 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2022 | 81537 | 0.050 |
Why?
|
Cerebellum | 1 | 2009 | 1519 | 0.050 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2002 | 101 | 0.050 |
Why?
|
Diabetic Neuropathies | 2 | 2002 | 407 | 0.050 |
Why?
|
Nociceptors | 2 | 2003 | 465 | 0.050 |
Why?
|
Risk Factors | 3 | 2022 | 74850 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6306 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2004 | 564 | 0.050 |
Why?
|
Caspase 3 | 1 | 2004 | 731 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 65194 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2022 | 6058 | 0.050 |
Why?
|
Glioma | 1 | 2016 | 3491 | 0.050 |
Why?
|
Afferent Pathways | 1 | 2002 | 303 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15878 | 0.050 |
Why?
|
Herpesvirus 3, Human | 1 | 2022 | 157 | 0.050 |
Why?
|
Warfarin | 1 | 2009 | 1494 | 0.050 |
Why?
|
Caspases | 1 | 2004 | 880 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6941 | 0.040 |
Why?
|
Immunohistochemistry | 5 | 2008 | 11030 | 0.040 |
Why?
|
Hemorrhage | 1 | 2012 | 3466 | 0.040 |
Why?
|
Equipment Failure | 1 | 2003 | 580 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3360 | 0.040 |
Why?
|
Adolescent | 7 | 2022 | 88811 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8722 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2017 | 59496 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39228 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2020 | 239 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2022 | 15802 | 0.040 |
Why?
|
Electroencephalography | 2 | 2022 | 6274 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2011 | 2538 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2003 | 1738 | 0.040 |
Why?
|
Disability Evaluation | 2 | 2019 | 1820 | 0.040 |
Why?
|
Hypothalamus | 1 | 2003 | 1005 | 0.040 |
Why?
|
Aspirin | 2 | 2020 | 3135 | 0.040 |
Why?
|
Neuropeptides | 1 | 2003 | 952 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2002 | 616 | 0.040 |
Why?
|
In Situ Hybridization | 3 | 2008 | 1885 | 0.040 |
Why?
|
Antibodies, Helminth | 1 | 2016 | 59 | 0.030 |
Why?
|
Antigens, Helminth | 1 | 2016 | 67 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2003 | 968 | 0.030 |
Why?
|
Taenia solium | 1 | 2016 | 28 | 0.030 |
Why?
|
Arthralgia | 1 | 2020 | 459 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2003 | 1273 | 0.030 |
Why?
|
Fetus | 1 | 2003 | 1878 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2270 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 2003 | 928 | 0.030 |
Why?
|
Exanthema | 1 | 2020 | 503 | 0.030 |
Why?
|
Postpartum Period | 1 | 2002 | 1195 | 0.030 |
Why?
|
Microglia | 1 | 2004 | 1369 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3249 | 0.030 |
Why?
|
Neuronal Plasticity | 1 | 2003 | 1446 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1343 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2003 | 1389 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 1936 | 0.030 |
Why?
|
Tanzania | 1 | 2019 | 1407 | 0.030 |
Why?
|
HIV-1 | 1 | 2012 | 6945 | 0.030 |
Why?
|
Occupations | 1 | 2016 | 516 | 0.030 |
Why?
|
Acyclovir | 1 | 2014 | 266 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1643 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 2019 | 640 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3690 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1553 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2114 | 0.030 |
Why?
|
Herpesvirus 2, Human | 1 | 2014 | 191 | 0.030 |
Why?
|
Logistic Models | 2 | 2017 | 13273 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14643 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2040 | 0.020 |
Why?
|
Gene Expression | 1 | 2003 | 7581 | 0.020 |
Why?
|
Ritonavir | 1 | 2012 | 331 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 2076 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2003 | 3965 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3801 | 0.020 |
Why?
|
Pain | 1 | 2004 | 5077 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9351 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8616 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2010 | 331 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2769 | 0.020 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2010 | 277 | 0.020 |
Why?
|
Aortography | 1 | 2010 | 423 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2003 | 18962 | 0.020 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2007 | 39 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2012 | 886 | 0.020 |
Why?
|
Angioplasty | 1 | 2010 | 353 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 4563 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3678 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 994 | 0.020 |
Why?
|
Computer Simulation | 1 | 1999 | 6251 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2075 | 0.020 |
Why?
|
Behavior, Animal | 2 | 2004 | 1866 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2008 | 924 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2019 | 3000 | 0.020 |
Why?
|
Incidental Findings | 1 | 2010 | 698 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6542 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 40097 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1881 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8725 | 0.010 |
Why?
|
Potassium Channels | 1 | 2007 | 534 | 0.010 |
Why?
|
Endarterectomy, Carotid | 1 | 2010 | 556 | 0.010 |
Why?
|
Developing Countries | 1 | 2017 | 2913 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2866 | 0.010 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2003 | 57 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42510 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8492 | 0.010 |
Why?
|
Prospective Studies | 2 | 2019 | 54807 | 0.010 |
Why?
|
Pain Measurement | 2 | 2004 | 3558 | 0.010 |
Why?
|
Ligation | 1 | 2004 | 445 | 0.010 |
Why?
|
Ion Channels | 1 | 2007 | 1044 | 0.010 |
Why?
|
Axotomy | 1 | 2002 | 71 | 0.010 |
Why?
|
Neural Pathways | 1 | 2013 | 3087 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2676 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4055 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2004 | 462 | 0.010 |
Why?
|
Electrophysiology | 1 | 2003 | 1264 | 0.010 |
Why?
|
Cell Size | 1 | 2002 | 626 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 2002 | 385 | 0.010 |
Why?
|
Hyperalgesia | 1 | 2004 | 511 | 0.010 |
Why?
|
Pelvic Pain | 1 | 2002 | 300 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 1823 | 0.010 |
Why?
|
Sciatic Nerve | 1 | 2002 | 623 | 0.010 |
Why?
|
Child | 2 | 2017 | 80568 | 0.010 |
Why?
|
Stents | 1 | 2010 | 3191 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21513 | 0.010 |
Why?
|
Mice | 1 | 2003 | 81782 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41680 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2002 | 1069 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26282 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2002 | 947 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36426 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15401 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16714 | 0.010 |
Why?
|
United States | 1 | 2016 | 72909 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2002 | 11895 | 0.000 |
Why?
|